UMIN-ICDS History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000062590
Receipt number	R000071643
Scientific Title	A multicenter prospective observational study of the effectiveness and safety of first-line amivantamab plus lazertinib combination therapy in EGFR-mutated non-small cell lung cancer
Date of disclosure of the study information	2026/08/17
Last modified on	2026/08/17 00:38:06

---